Atrial Arrhythmia
45
9
15
18
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 45 trials
100.0%
+13.5% vs benchmark
4%
2 trials in Phase 3/4
11%
2 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (45)
A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure
PulseMagic™ TrueForce™ PAF NMPA Study
Anatomical Navigation for Guided Electrophysiology in AFL and AFib
Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures
Registry on Luma Vision's VERAFEYE System (ENLIgHT)
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
VOLta Medical AI-software in REal-World During AF Ablation
Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients
VOLT-AF IDE Clinical Study
VOLT CE Mark Study
ATrial Tachycardia PAcing Therapy in Congenital Heart
AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function
Feasibility Study on the VERAFEYE System
Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation
Study of AHRE Burden in Patients Undergoing Bachmann Bundle Area Pacing and Left Bundle Branch Pacing.
Hybrid Ablation of Atrial Fibrillation in Heart Failure
Abbott Atrial Fibrillation Post Approval Study